Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Desmethylfluoxetine
2. Norfluoxetin
3. Norfluoxetine Hydrochloride
4. Norfluoxetine, (+-)-isomer
1. 83891-03-6
2. Desmethylfluoxetine
3. 56161-73-0
4. 3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine
5. 3-phenyl-3-(4-(trifluoromethyl)phenoxy)propan-1-amine
6. 3-phenyl-3-(4-trifluoromethyl-phenoxy)-propylamine
7. K8d70xe2f4
8. Benzenepropanamine, Gamma-(4-(trifluoromethyl)phenoxy)-
9. Benzenepropanamine, Gamma-[4-(trifluoromethyl)phenoxy]-
10. Unii-k8d70xe2f4
11. Gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
12. Chembl1494
13. Gtpl208
14. Schembl686500
15. Dtxsid80866540
16. Chebi:180876
17. (+/-)-desmethylfluoxetine
18. Bcp20944
19. Bdbm50180661
20. Nsc675448
21. Akos015911091
22. Norfluoxetine Hcl;n-desmethylfluoxetine
23. Nsc-675448
24. Sb32578
25. Sb32682
26. Sb38941
27. Ft-0673087
28. Ft-0673088
29. Ft-0673089
30. 3-(4-trifluoromethylphenoxy)-3-phenylproplyamine
31. A840679
32. L001023
33. Q7452012
34. 3-phenyl-3-[4-(triluoromethyl)phenoxy]propan-1-amine
35. 3-phenyl-3[4'-trifluoromethyl-phenoxy]-propan-1-amine
36. 3-phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propanamine #
37. Benzenepropanamine, .gamma.-[4-(trifluoromethyl)phenoxy]-
38. Benzenepropanamine, Gamma-[4-(trifluoromethyl)phenoxy]-, (+/-)-
39. Benzenepropanamine, .gamma.-(4-(trifluoromethyl)phenoxy)-, (+/-)-
| Molecular Weight | 295.30 g/mol |
|---|---|
| Molecular Formula | C16H16F3NO |
| XLogP3 | 3.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Exact Mass | 295.11839862 g/mol |
| Monoisotopic Mass | 295.11839862 g/mol |
| Topological Polar Surface Area | 35.2 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 294 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Norfluoxetine is a known human metabolite of Fluoxetine.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
ANALYTICAL
ABOUT THIS PAGE
A Norfluoxetine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Norfluoxetine, including repackagers and relabelers. The FDA regulates Norfluoxetine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Norfluoxetine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Norfluoxetine supplier is an individual or a company that provides Norfluoxetine active pharmaceutical ingredient (API) or Norfluoxetine finished formulations upon request. The Norfluoxetine suppliers may include Norfluoxetine API manufacturers, exporters, distributors and traders.
Norfluoxetine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Norfluoxetine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Norfluoxetine GMP manufacturer or Norfluoxetine GMP API supplier for your needs.
A Norfluoxetine CoA (Certificate of Analysis) is a formal document that attests to Norfluoxetine's compliance with Norfluoxetine specifications and serves as a tool for batch-level quality control.
Norfluoxetine CoA mostly includes findings from lab analyses of a specific batch. For each Norfluoxetine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Norfluoxetine may be tested according to a variety of international standards, such as European Pharmacopoeia (Norfluoxetine EP), Norfluoxetine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Norfluoxetine USP).
LOOKING FOR A SUPPLIER?
